Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyReferences
- Plasma cholesteryl ester transfer protein.J Lipid Res. 1993; 34: 1255-1274
- Seasonal pattern of incidence and case fatality of acute myocardial infarction in a Japanese population (from the Takashima AMI Registry, 1988–2003).Am J Cardiol. 2008; 102: 1307-1311
- Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: the Suita study.Atherosclerosis. 2009; 203: 587-592
- Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.J Clin Invest. 1994; 94: 1872-1882
- Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-World War II birth cohort.Am J Epidemiol. 2007; 165: 617-624
- Alcohol consumption and coronary artery calcium in middle-aged Japanese men.Am J Cardiol. 2006; 98: 141-144
- Fish consumption and early atherosclerosis in middle-aged men.Metabolism. 2007; 56: 1060-1064
- Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese Americans, and whites: a cross-sectional study.J Am Coll Cardiol. 2008; 52: 417-424
- Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients.Clin Chem. 1998; 44: 1466-1473
- Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the Suita study.Hypertens Res. 2008; 31: 2027-2035
- Quantification of coronary artery calcium using ultrafast computed tomography.J Am Coll Cardiol. 1990; 15: 827-832
- Continuous quality assessment programs can improve carotid duplex scan quality.J vasc Technol. 2001; 25: 33-39
- Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.Arterioscler Thromb Vasc Biol. 2003; 23: 160-167
- Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.Arterioscler Thromb Vasc Biol. 1997; 17: 1053-1059
- Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.Circulation. 2004; 110: 1418-1423
- Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness.J Mol Med. 1995; 73: 369-372
- Serum cholesteryl ester transfer protein concentrations in healthy Chinese subjects and cardio-cerebrovascular disease patients.Clinica Chim Acta. 2001; 305: 19-25
- Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).Eur J Clin Invest. 2004; 34: 21-28
- Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.Diabetes. 2001; 50: 652-659
- Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.Diabetes. 2005; 54 (3554–2559)
- Effects of torcetrapib in patients at high risk for coronary events.N Engl J Med. 2007; 357: 2109-2122
- Effect of torcetrapib on the progression of coronary atherosclerosis.N Engl J Med. 2007; 356: 1304-1316
- Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.Lancet. 2007; 370: 153-160
- Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.Circulation. 2008; 118: 2515-2522
- A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly.J Lipid Res. 2004; 45: 948-953
- Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.Arterioscler Thromb Vasc Biol. 1997; 17: 1053-1059
- A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.Prev Med. 1998; 27: 659-667
- Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation).Circulation. 2008; 118: 2506-2514
- Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.Diabetes Care. 2003; 26: 1216-1223
Article info
Publication history
Footnotes
This research was supported by Grants R01 HL68200 and HL071561 from the National Institutes of Health, Bethesda, Maryland; by a Grant-in-Aid for Scientific Research, Grants C18590595 and C20590670, from the Japan Society for the Promotion of Science, Tokyo, Japan; and by a Grant-in-Aid for Scientific Research, Grant A13307016, by the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan.